PR Newswire
Elisabeth Heath, M.D., Associate Center Director for Translational Sciences, Karmanos Cancer Institute, comments on Caris Life Sciences’ announcement of positive results from a study using MI GPSai™ (Genomic Prevalence Score), an artificial intelligence-driven product using DNA sequencing and whole transcriptome data to aid in the diagnosis of cancer.
Read the full article here.